Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine
…, A Mazhnaya, J Kowalska, S Bhagani, C Rokx - The Lancet …, 2022 - thelancet.com
Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war
on the European continent has affected HIV care in Ukraine in an unprecedented way. …
on the European continent has affected HIV care in Ukraine in an unprecedented way. …
[HTML][HTML] An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
…, CWE Embregts, BM Laksono, L Leijten, C Rokx… - Nature …, 2020 - nature.com
The world is entering a new era of the COVID-19 pandemic in which there is an increasing
call for reliable antibody testing. To support decision making on the deployment of serology …
call for reliable antibody testing. To support decision making on the deployment of serology …
Convalescent plasma for COVID-19. A randomized clinical trial
…, MPG Koopmans, BHG Haagmans, C Rokx… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
[HTML][HTML] Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
…, MPG Koopmans, BL Haagmans, C Rokx… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
[HTML][HTML] Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
…, O Mor, C Charpentier, E Todesco, C Rokx… - The Lancet infectious …, 2016 - thelancet.com
Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …
Coronavirus disease 2019 convalescent plasma outpatient therapy to prevent outpatient hospitalization: a meta-analysis of individual participant data from 5 …
…, BJA Rijnders, A Gharbharan, C Rokx… - Clinical Infectious …, 2023 - academic.oup.com
Background Outpatient monoclonal antibodies are no longer effective and antiviral treatments
for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many …
for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many …
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial
I Wijting, C Rokx, C Boucher, J van Kampen, S Pas… - The lancet HIV, 2017 - thelancet.com
Background The high genetic barrier to resistance of dolutegravir might allow for its use as
maintenance monotherapy in patients with HIV. We investigated whether dolutegravir …
maintenance monotherapy in patients with HIV. We investigated whether dolutegravir …
[HTML][HTML] Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning
…, M Hernández-González, C Rokx… - Nature …, 2022 - nature.com
Quantitative or qualitative differences in immunity may drive clinical severity in COVID-19.
Although longitudinal studies to record the course of immunological changes are ample, they …
Although longitudinal studies to record the course of immunological changes are ample, they …
Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis
…, L Pirofski, BJA Rijnders, C Rokx… - JAMA Network …, 2022 - jamanetwork.com
Importance COVID-19 convalescent plasma (CCP) is a potentially beneficial treatment for
COVID-19 that requires rigorous testing. Objective To compile individual patient data from …
COVID-19 that requires rigorous testing. Objective To compile individual patient data from …
[HTML][HTML] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
…, K Brinkman, AHE Roukens, C Rokx - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …